An Open-Label, Randomized, Single-Dose, Two-Sequence, Two-Treatment, Four-Period, Crossover Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex in Healthy Subjects With Cannabis Experience

Trial Profile

An Open-Label, Randomized, Single-Dose, Two-Sequence, Two-Treatment, Four-Period, Crossover Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex in Healthy Subjects With Cannabis Experience

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Aug 2015

At a glance

  • Drugs Nabiximols (Primary) ; Fluconazole
  • Indications Bladder dysfunction; Cancer pain; Glioblastoma; Muscle spasticity; Neuropathic pain; Stomatitis
  • Focus Pharmacokinetics
  • Sponsors GW Pharmaceuticals
  • Most Recent Events

    • 13 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 30 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top